Artemoin D



Compound IDCDAMM02282
Common nameArtemoin D
IUPAC name4-(13,14-dihydroxytriacontyl)-2-methyl-2H-furan-5-one
Molecular formulaC35H66O4

Experimental data

Retention time14.66
Adduct[M+H]+
Actual mz551.503
Theoretical mz551.503
Error0.86
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.1251

Identifiers and class information

Inchi keyCAGLXILDKKCMCR-UHFFFAOYNA-N
SmilesO=C1OC(C=C1CCCCCCCCCCCCC(O)C(O)CCCCCCCCCCCCCCCC)C
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)31
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)550.904
Computed dipole moment(dipole)5.846
Total solvent accessible surface area (SASA)1253.76
Hydrophobic component of SASA (FOSA)1096.05
Hydrophilic component of SASA (FISA)124.48
Pie component of the SASA (PISA)33.228
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2229.24
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)6.4
Free energy of solvation of dipole (dip^2/V)0.0153323
Index of cohesive interaction in solids (ACxDN^.5/SA)0.007219
Globularity descriptor (glob)0.658246
Predicted polarizability in cubic angstroms (QPpolrz)63.473
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.618
Predicted octanol/gas partition coefficient (QPlogPoct)26.004
Predicted water/gas partition coefficient (QPlogPw)6.204
Predicted octanol/water partition coefficient (QPlogPo/w)9.62
Predicted aqueous solubility (QPlogS)-11.497
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.03
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.22
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)653.811
Predicted brain/blood partition coefficient (QPlogBB)-3.22
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)312.519
Predicted skin permeability, log Kp (QPlogKp)-0.72
PM3 calculated ionization potential (IP(ev))10.608
PM3 calculated electron affinity (EA(eV))0.452
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)2.005
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)80.368
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P43116PTGER2Prostanoid EP2 receptorT38529SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P19971TYMPThymidine phosphorylaseT59929SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
Q99500S1PR3Sphingosine 1-phosphate receptor Edg-3T11241SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
O95977S1PR4Sphingosine 1-phosphate receptor Edg-6T17523SEA
Q9NQS5GPR84G-protein coupled receptor 84T98091SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T38529DI0003Abortion[ICD-11: JA00]P43116PTGER2
T38529DI0102Coronary atherosclerosis[ICD-11: BA52]P43116PTGER2
T38529DI0121Diabetic foot ulcer[ICD-11: BD54]P43116PTGER2
T38529DI0166Glaucoma[ICD-11: 9C61]P43116PTGER2
T38529DI0356Pulmonary hypertension[ICD-11: BB01]P43116PTGER2
T38529DI0378Sexual dysfunction[ICD-11: HA00-HA01]P43116PTGER2
T38529DI0413Transplant rejection[ICD-11: NE84]P43116PTGER2
T59929DI0117Depression[ICD-11: 6A70-6A7Z]P19971TYMP
T11241DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q99500S1PR3
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T98091DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q9NQS5GPR84
T98091DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q9NQS5GPR84

Copyright © 2025